Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gammaitoni

Showing results (181-190 of 230) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 AntibodyMartina Sanlorenzo, Igor Vujic, Arianna Floris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriersMaja Todorovic, Giulia Mesiano, Loretta Gammaitoni, et al.
BMC Cancer|May 9, 2015
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesotheliomaYmera Pignochino, Carmine Dell'Aglio, Simona Inghilleri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2013
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness featuresLoretta Gammaitoni, Lidia Giraudo, Valeria Leuci, et al.
Cancer Research|December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomasDario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Blood|June 30, 2010
Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signalingMelania Tesio, Karin Golan, Simona Corso, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2017
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched DonorsFabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem CellsLoretta Gammaitoni, Lidia Giraudo, Marco Macagno, et al.
Pageof 23

Showing results (181-190 of 230) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 AntibodyMartina Sanlorenzo, Igor Vujic, Arianna Floris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2012
Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriersMaja Todorovic, Giulia Mesiano, Loretta Gammaitoni, et al.
BMC Cancer|May 9, 2015
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesotheliomaYmera Pignochino, Carmine Dell'Aglio, Simona Inghilleri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2013
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness featuresLoretta Gammaitoni, Lidia Giraudo, Valeria Leuci, et al.
Cancer Research|December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomasDario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Blood|June 30, 2010
Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signalingMelania Tesio, Karin Golan, Simona Corso, et al.
Lancet (London, England)|December 22, 2019
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trialLieven Lagae, Joseph Sullivan, Kelly Knupp, et al.
Epilepsia|August 6, 2023
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo-controlled clinical trialJoseph Sullivan, Lieven Lagae, J Helen Cross, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2017
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched DonorsFabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2016
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem CellsLoretta Gammaitoni, Lidia Giraudo, Marco Macagno, et al.
Pageof 23